GSS' quarterly was a lot like a bikini......what it revealed was interesting, what it concealed is vital!
Management just doesn't believe in talking their prospects up.....and its up to us to fill in the gaps
the delays with FDA approval is a function of the bureaucracy being under extreme duress; its a matter of when its approved, not if.....
frustrating....but, that's the US
unlike here and Europe where Labs can use a test prior to formal approval ( the Lab takes responsibility for its accuracy ), the Labs cant do that in the US
they most interesting thing was the cash burn for inventory.....obviously they're holding a lot of inventory in anticipation of much higher demand.....why else would one allocate almost 20% of one's available cash to this end?....i think they're smart.....they've had to pay COD for raw materials now because they know they will sell it
I received the Bell Potter analysis last night, the author really gets GSS and she's been right all the way
not surprised in any way to see her upgrade
- Forums
- ASX - By Stock
- GSS
- Ann: Investor presentation
Ann: Investor presentation, page-20
Featured News
Add GSS (ASX) to my watchlist
|
|||||
Last
77.0¢ |
Change
0.010(1.32%) |
Mkt cap ! $174.4M |
Open | High | Low | Value | Volume |
75.5¢ | 77.0¢ | 75.0¢ | $47.29K | 62.58K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 70368 | 75.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
77.0¢ | 66559 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 70368 | 0.750 |
1 | 1000 | 0.740 |
1 | 5000 | 0.735 |
4 | 103069 | 0.730 |
2 | 8500 | 0.720 |
Price($) | Vol. | No. |
---|---|---|
0.770 | 66559 | 3 |
0.780 | 159109 | 2 |
0.795 | 9997 | 1 |
0.800 | 150999 | 3 |
0.820 | 2048 | 1 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online